CART cell therapy for prostate cancer: status and promise
Haiyuan Yu,1,* Jun Pan,1,* Zhicheng Guo,1 Chunhua Yang,1,2 Lijun Mao1,2 1Department of Urinary Surgery, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, China; 2Jiangsu Key Laboratory of Biological Cancer Therapy, Department of Clinic Institute, Xuzhou Medical University, Xuzhou...
Main Authors: | Yu H, Pan J, Guo Z, Yang C, Mao L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-01-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/cart-cell-therapy-for-prostate-cancer-status-and-promise-peer-reviewed-article-OTT |
Similar Items
-
CAR-T cell therapy: a potential new strategy against prostate cancer
by: Giuseppe Schepisi, et al.
Published: (2019-10-01) -
Chimeric Antigen Receptor-Engineered T Cell Therapy for the Management of Patients with Metastatic Prostate Cancer: A Comprehensive Review
by: Young Dong Yu, et al.
Published: (2021-01-01) -
Anti-PSMA CAR-engineered NK-92 Cells: An Off-the-shelf Cell Therapy for Prostate Cancer
by: Isabella Monia Montagner, et al.
Published: (2020-06-01) -
PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB “Super-Stimulation”
by: Gaia Zuccolotto, et al.
Published: (2021-09-01) -
Current Perspectives on the Use of off the Shelf CAR-T/NK Cells for the Treatment of Cancer
by: Lauren C. Cutmore, et al.
Published: (2021-04-01)